CBD: A Hope for Epilepsy Patients

Curtis Howell PURE CBD Leave a Comment

What can be done about the use of CBD as a potential treatment for numerous mitigating diseases like diabetes, Crohn’s, fibromyalgia, heart disease, chronic pain, multiple sclerosis, and neurologic conditions, including epilepsy, is a highly debated issue. Not only is there a lack of scientific research on the safety and usefulness of the drug, but there are also plenty legal issues surrounding the access of CBD. Nevertheless, despite the legal issues, there is no doubt in the fact that CBD is actually a HOPE for epilepsy patients. Don’t believe us? Take a look at this scientific research below:

An Open-Labeled Study in the U.S of Epidiolex

For those of you who don’t know, Epidiolex is a drug that is derived from cannabidiol. It is a purified, 99% oil-based extract of CBD that is produced by GM Pharmaceuticals and is primarily used for the treatment of epilepsy and related conditions. For now, the U.S. Food and Drug Administration (FDA) has given some healthcare centers permission to use Epidiolex for difficult epilepsies like Dravet syndrome in children and Lennox-Gastaut syndrome in Adults.

Moving on, an open-label study presented at the American Academy of Neurology on April 22, 2015 revealed results from 213 people who received Epidiolex. Data presented showed 137 people (aged from 2 to 24 years old) who completed more than 12 weeks on the drug and how it proved useful in eliminating the neurologic conditions. All of these people receiving treatment did not gain any beneficial results from other epileptic-related drugs. Statistics revealed were:

  • People who were taking medication with anti-seizure properties like Clobazam, along with Epidiolex experienced better improvement in convulsive seizures, as compared to those people who were not taking Clobazam. The doctors suggest that a mixture of Epidiolex and Clobazam may be useful in treating various epileptic-related diseases.
  • The responder rate of those people consuming Epidiolex (seizures reduced by at least 50%) was better than those patients taking DS. This reveals that Epidiolex proves more effective than DS in treating patients with epilepsy.
  • 27 patients suffering with atonic seizures consumed Epidiolex. The results showed the atonic seizures were reduced by 66.7% on average.
  • The improvement in seizures for those people consuming Epidiolex lasted for 24 weeks, which is definitely better as compared to those people with DS.
  • A 63% decrease in overall seizures was noticed in Patients who had DS, over a period of 3 months.
  • The seizures in all 137 people who completed 12 weeks on Epidiolex were reduced by an average of 54%.

As you can see, the epileptic conditions that CBD proves effective against are extremely powerful and complex. In fact, even well-research drugs have not been capable of inducing any healing affect. But, Epidiolex has! So, why is the drug still not being administered publicly to help patients with epileptic conditions? The reason remains unknown, but all we can do is: hope for the best!

Leave a Reply